Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchhuonspeptidesmrnaadc

Huons Partners With Three Biotechs on mRNA, ADC, Peptide Drugs

Korean drugmaker signs collaborations spanning mRNA, antibody-drug conjugates and peptide therapeutic programs.

PR
By Priya Raman · Science Reporter
Sep 15 02:56 ETSource: Korea Biomedical Review

The wire

  1. 01Huons announced tie-ups with three biotech firms across three modalities.
  2. 02Deal expands the company's pipeline into peptide and advanced-modality drugs.
  3. 03Program details, timelines and financial terms not disclosed.

From the source

Huons teams with 3 biotechs on mRNA, ADC, peptide drug projects

Read at news.google.com
Source URL https://news.google.com/rss/articles/CBMickFVX3lxTE9Fa2s5Z3lOMlI2M056emxhZlZndzd6b2h2bFd1bnhOV0hMTDNPNWRaZ0VqWWtrV1Nvak1FOTBzSDgyY2twaHYxYVhuUmdmbEVwd0lsQWZ5Z2ZhZnZvUUZhRU1JOTVPa2o0QWRLVWU4VnR0UdIBckFVX3lxTE9Fa2s5Z3lOMlI2M056emxhZlZndzd6b2h2bFd1bnhOV0hMTDNPNWRaZ0VqWWtrV1Nvak1FOTBzSDgyY2twaHYxYVhuUmdmbEVwd0lsQWZ5Z2ZhZnZvUUZhRU1JOTVPa2o0QWRLVWU4VnR0UQ?oc=5